Moreover, studies (Dai et al. 2019) have confirmed that liver cancer cells with decreased CLEC3B expression secrete substances that promote tumor cell and endothelial cell invasion and migration while inhibiting angiogenesis. The gene discussed is CLEC3B; the disease is neoplasm.